T3 Defense Inc. (NASDAQ:DFNS) shares are up on Monday, trading higher by more than 70%.
Short seller Fugazi Research released a bearish report questioning the company’s financial performance, capital structure and acquisition strategy.
Short Seller Highlights Large Losses
Fugazi alleged that T3 Defense’s recent growth narrative has been driven primarily by capital markets activity and equity issuance rather than sustainable operating performance.
According to the report, T3 Defense generated $3.6 million in revenue in the first quarter of 2026 but reported a net loss of $26.3 million.
The short seller noted that gross profit totaled approximately $371,000, compared with more than $4 million in operating expenses, raising concerns about the company’s ability to generate sustainable earnings.
The report argued that DFNS continues to face significant operating losses despite operating in a defense market benefiting from increased government spending and demand for advanced technologies.
Concerns Over Share Dilution
Fugazi Research also raised concerns about DFNS’ reverse split and acquisition approach. The report highlighted that T3 Defense increased its planned reverse split ratio from 1-for-50 to 1-for-125 after receiving a Nasdaq minimum bid price deficiency notice.
The short seller compared DFNS’ current strategy with previous activity involving Nukkleus, alleging similarities in the sequence of reverse split activity, acquisition announcements and subsequent share issuance.
Benzinga has reached out to T3 Defense for comments and is yet to receive a response.
Sustainability
The report says that the cash, cash equivalents, and restricted cash stood at $7.6 million at quarter-end against $4.9 million in quarterly operating cash burn, representing approximately 4.7 months of runway (with actual usable liquidity even lower due to restrictions).
It alleged that the Goodwill soared from $7.6 million at year-end 2025 to $100 million by March 31, 2026, driven almost entirely by paper-funded asset acquisitions rather than organic cash flow or physical asset accumulation.
Fugazi Research concludes that DFNS (formerly Nukkleus Inc.) is fundamentally uninvestable at any price above zero, alleging the company’s true "primary product" is its hyper-dilutive capital structure rather than an operational defense business.
Subsidiaries Report Record Revenue And Backlog
Notably, on Friday, the company reported strong year-to-date operating performance from its subsidiaries, Rimon and Tiltan.
Rimon recorded monthly revenue of $2.6 million in July 2026, marking an all-time high. Year-to-date revenue reached approximately $5.25 million, already exceeding the company’s full-year 2025 revenue of $4.6 million.
Rimon anticipates full-year 2026 revenue to exceed $7.2 million, driven by significant growth in activity volumes and deliveries within Israel’s defense industry.
Apart from this, Tiltan reported about $1.0 million in year-to-date revenue, with total purchase orders received reaching $2.5 million.
As of July 31, 2026, the company had a backlog of $1.5 million and an additional $3.5 million in outstanding proposals awaiting conversion into orders.
Tiltan is also expected to surpass $4.0 million in revenue for the same period, bolstered by orders for advanced aerial sensors from leading global defense customers.
What T3 Defense (DFNS) Does And Its Defense Portfolio
T3 Defense is a holding company that acquires and operates defense businesses involved in national security programs.
The company operates as a strategic platform, building a portfolio of mission-critical suppliers and technology companies, including those focused on defense and aerospace technologies such as AI software and unmanned aerial systems.
DFNS Price Action: T3 Defense shares were up 61.16% at $44.61 at the time of publication on Monday, according to Benzinga Pro data.
Photo via Shutterstock
Login to comment